Phenovista is a life sciences services company developing and implementing multiplexed, high content imaging-based phenotypic assays for target validation, lead optimization, and mechanism of action studies. The company delivers high-quality, quantitative data to inform and de-risk critical R&D decisions with greater confidence for biopharmaceutical clients.